查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1953987

日本分子诊断市场报告：按产品、技术、应用、最终用户和地区划分（2026-2034年）

Japan Molecular Diagnostics Market Report by Product, Technology (Polymerase Chain Reactions, Hybridization, DNA Sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology, and Others), Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本分子诊断市场规模达13亿美元。 IMARC集团预测，到2034年，该市场规模将达到22亿美元，2026年至2034年的复合年增长率（CAGR）为5.90%。癌症和心血管疾病等慢性病的增加、老年人口的成长（老年人有特殊的医疗需求，患有某些疾病的风险也更高）以及次世代定序和即时PCR等先进技术的应用，都是推动市场成长的关键因素。

分子诊断是指用于分析基因组和蛋白质组中生物标记的一系列技术。这个诊断类别使医疗专业人员能够检测和测量与特定健康状况和疾病相关的遗传物质和蛋白质的存在。分子诊断的特点是精确、准确和快速，并在医疗保健系统中发挥至关重要的作用。这些诊断方法利用聚合酵素链锁反应(PCR)、原位杂合反应(ISH) 和 DNA定序等技术来揭示特定的遗传讯息。其作用机制包括遗传物质的萃取、扩增和分析，首先分离 DNA 或 RNA，然后扩增目标基因区域。扩增的遗传物质随后使用各种技术进行检测，以识别突变和改变，使医疗专业人员能够做出明智的诊断和治疗决策。分子诊断的特性，例如灵敏度、特异性和同时处理多个检体的能力，在提供及时和个人化医疗保健方面具有优势，并为个人化医疗提供了一个前景广阔的系统。

日本分子诊断市场的发展趋势：

日本市场的主要驱动力是慢性病（包括癌症和心血管疾病）的增加，促使人们对早期精准检测的需求日益增长。而这又受到老年人口不断增加的推动，老年人口的特殊医疗需求以及患有某些疾病风险的增加。此外，次世代定序和即时PCR等先进技术的整合也是推动市场成长的关键因素。同时，日本政府持续提供的财政支持和有利的监管政策也为研发创造了更有利的环境。此外，人们对个人化医疗的认识不断提高，以及学术机构和私人企业之间研究合作的日益重视，都为市场创造了盈利的机会。分子诊断平台在各种医疗机构的广泛应用也对市场产生了正面影响。此外，对医疗基础设施的大力投资以及公共卫生目标与技术创新之间的策略性结合也在推动市场发展。以预防保健和早期诊断为重点的健康保险的普及，以及专业实验室和诊所数量的不断增加，也都在推动市场成长。其他市场成长要素包括日本受过高等教育的劳动力、先进的医疗保健系统以及重视医学科学和技术的精准性和创新性的文化背景。

日本分子诊断市场细分：

产品洞察：

本报告解答的关键问题：

  • 目前日本分子诊断市场的发展趋势是什么？您对未来几年的发展趋势有何预测？
  • 新冠疫情对日本分子诊断市场产生了哪些影响？
  • 日本分子诊断市场的产品组成是怎样的？
  • 日本分子诊断市场按技术是如何细分的？
  • 日本分子诊断市场按应用领域分類的组成是怎样的？
  • 日本分子诊断市场依最终用户分類的组成是怎样的？
  • 请介绍一下日本分子诊断市场价值链的各个环节。
  • 日本分子诊断市场的主要驱动因素和挑战是什么？
  • 日本分子诊断市场的结构是怎么样的？主要参与者有哪些？
  • 日本分子诊断市场的竞争程度如何？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章：日本分子诊断市场：简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章：日本分子诊断市场概况

  • 过去和当前的市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章：日本分子诊断市场：依产品细分

  • 试剂和试剂盒
  • 装置
  • 软体和服务

第七章 日本分子诊断市场－依技术细分

  • 聚合酵素链锁反应（PCR）
  • 杂合反应
  • DNA定序
  • 微阵列
  • 恒温核酸增幅技术（INAAT）
  • 其他的

第八章：日本分子诊断市场：依应用领域细分

  • 感染疾病诊断
  • 肿瘤学
  • 基因检测
  • 血液筛检
  • 其他的

第九章 日本分子诊断市场－依最终用户细分

  • 医院
  • 检查机构
  • 其他的

第十章：日本分子诊断市场：依地区划分

  • 关东地区
  • 近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十一章：日本分子诊断市场：竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十二章主要企业概况

第十三章：日本分子诊断市场：产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十四章附录

简介目录
Product Code: SR112026A11068

The Japan molecular diagnostics market size reached USD 1.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.2 Billion by 2034, exhibiting a growth rate (CAGR) of 5.90% during 2026-2034. The increasing prevalence of chronic diseases, including cancer and cardiovascular ailments, the growing geriatric population requiring unique healthcare needs and a higher propensity for specific diseases, and the integration of advanced technologies such as next-generation sequencing and real-time PCR represent some of the key factors driving the market.

Molecular diagnostics refers to a collection of techniques used to analyze biological markers in the genome and proteome. This category of diagnostics enables medical professionals to detect and measure the presence of genetic material or proteins associated with a specific health condition or disease state. Molecular diagnostics are characterized by their precision, accuracy, and speed, as well as their essential role in the healthcare system. These diagnostic methods employ technologies such as PCR (polymerase chain reaction), ISH (in situ hybridization), and DNA sequencing to uncover specific genetic information. Their working mechanism involves extracting, amplifying, and analyzing genetic material, starting with the isolation of DNA or RNA to amplify targeted genetic regions. The amplified genetic material is then examined through various methods to identify mutations or changes, enabling healthcare providers to make informed decisions about diagnosis and treatment. The properties of molecular diagnostics such as sensitivity, specificity, and the ability to process multiple samples simultaneously make them advantageous in providing timely and tailored medical treatments, thereby offering a promising system to personalized medicine.

Japan Molecular Diagnostics Market Trends:

The market in Japan is primarily driven by the increasing prevalence of chronic diseases, including cancer and cardiovascular ailments, which necessitates the need for early and precise detection. In line with this, the growing geriatric population in Japan, requiring unique healthcare needs and a higher propensity for specific diseases, is also providing an impetus to the market. Moreover, the integration of advanced technologies such as next-generation sequencing and real-time PCR is acting as a significant growth-inducing factor for the market. In addition to this, the consistent support from the Japanese government in terms of funding and favorable regulatory guidelines is resulting in a more conducive environment for research and development. Besides this, the growing awareness about personalized medicine, coupled with a strong emphasis on research collaboration between academic institutions and private enterprises, is creating lucrative opportunities in the market. Also, the wide availability of molecular diagnostic platforms across various healthcare settings is impacting the market positively. The market is further driven by the robust investment in healthcare infrastructure and the strategic alignment of public health goals with technological innovation. Apart from this, the penetration of health insurance, focusing on preventive care and early diagnosis, along with the proliferation of specialized laboratories and clinics, is propelling the market. Some of the other factors contributing to the market include Japan's highly educated workforce, sophisticated healthcare system, and a cultural emphasis on precision and innovation in medical science and technology.

Japan Molecular Diagnostics Market Segmentation:

Product Insights:

  • Reagents and Kits
  • Instruments
  • Software and Services

Technology Insights:

  • Polymerase Chain Reactions (PCR)
  • Hybridization
  • DNA Sequencing
  • Microarray
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Others

Application Insights:

  • Infectious Diseases Diagnostics
  • Oncology
  • Genetic Testing
  • Blood Screening
  • Others

End User Insights:

  • Hospitals
  • Laboratories
  • Others

Regional Insights:

  • Kanto Region
  • Kinki Region
  • Central/Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Central/Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan molecular diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan molecular diagnostics market?
  • What is the breakup of the Japan molecular diagnostics market on the basis of product?
  • What is the breakup of the Japan molecular diagnostics market on the basis of technology?
  • What is the breakup of the Japan molecular diagnostics market on the basis of application?
  • What is the breakup of the Japan molecular diagnostics market on the basis of end user?
  • What are the various stages in the value chain of the Japan molecular diagnostics market?
  • What are the key driving factors and challenges in the Japan molecular diagnostics market?
  • What is the structure of the Japan molecular diagnostics market and who are the key players?
  • What is the degree of competition in the Japan molecular diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Molecular Diagnostics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Molecular Diagnostics Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Molecular Diagnostics Market - Breakup by Product

  • 6.1 Reagents and Kits
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Instruments
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Software and Services
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)

7 Japan Molecular Diagnostics Market - Breakup by Technology

  • 7.1 Polymerase Chain Reactions (PCR)
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Hybridization
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 DNA Sequencing
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Microarray
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2020-2025)
    • 7.5.3 Market Forecast (2026-2034)
  • 7.6 Others
    • 7.6.1 Historical and Current Market Trends (2020-2025)
    • 7.6.2 Market Forecast (2026-2034)

8 Japan Molecular Diagnostics Market - Breakup by Application

  • 8.1 Infectious Diseases Diagnostics
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Oncology
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Genetic Testing
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)
  • 8.4 Blood Screening
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Forecast (2026-2034)
  • 8.5 Others
    • 8.5.1 Historical and Current Market Trends (2020-2025)
    • 8.5.2 Market Forecast (2026-2034)

9 Japan Molecular Diagnostics Market - Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 Laboratories
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)
  • 9.3 Others
    • 9.3.1 Historical and Current Market Trends (2020-2025)
    • 9.3.2 Market Forecast (2026-2034)

10 Japan Molecular Diagnostics Market - Breakup by Region

  • 10.1 Kanto Region
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Breakup by Product
    • 10.1.4 Market Breakup by Technology
    • 10.1.5 Market Breakup by Application
    • 10.1.6 Market Breakup by End User
    • 10.1.7 Key Players
    • 10.1.8 Market Forecast (2026-2034)
  • 10.2 Kinki Region
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Breakup by Product
    • 10.2.4 Market Breakup by Technology
    • 10.2.5 Market Breakup by Application
    • 10.2.6 Market Breakup by End User
    • 10.2.7 Key Players
    • 10.2.8 Market Forecast (2026-2034)
  • 10.3 Central/ Chubu Region
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2020-2025)
    • 10.3.3 Market Breakup by Product
    • 10.3.4 Market Breakup by Technology
    • 10.3.5 Market Breakup by Application
    • 10.3.6 Market Breakup by End User
    • 10.3.7 Key Players
    • 10.3.8 Market Forecast (2026-2034)
  • 10.4 Kyushu-Okinawa Region
    • 10.4.1 Overview
    • 10.4.2 Historical and Current Market Trends (2020-2025)
    • 10.4.3 Market Breakup by Product
    • 10.4.4 Market Breakup by Technology
    • 10.4.5 Market Breakup by Application
    • 10.4.6 Market Breakup by End User
    • 10.4.7 Key Players
    • 10.4.8 Market Forecast (2026-2034)
  • 10.5 Tohoku Region
    • 10.5.1 Overview
    • 10.5.2 Historical and Current Market Trends (2020-2025)
    • 10.5.3 Market Breakup by Product
    • 10.5.4 Market Breakup by Technology
    • 10.5.5 Market Breakup by Application
    • 10.5.6 Market Breakup by End User
    • 10.5.7 Key Players
    • 10.5.8 Market Forecast (2026-2034)
  • 10.6 Chugoku Region
    • 10.6.1 Overview
    • 10.6.2 Historical and Current Market Trends (2020-2025)
    • 10.6.3 Market Breakup by Product
    • 10.6.4 Market Breakup by Technology
    • 10.6.5 Market Breakup by Application
    • 10.6.6 Market Breakup by End User
    • 10.6.7 Key Players
    • 10.6.8 Market Forecast (2026-2034)
  • 10.7 Hokkaido Region
    • 10.7.1 Overview
    • 10.7.2 Historical and Current Market Trends (2020-2025)
    • 10.7.3 Market Breakup by Product
    • 10.7.4 Market Breakup by Technology
    • 10.7.5 Market Breakup by Application
    • 10.7.6 Market Breakup by End User
    • 10.7.7 Key Players
    • 10.7.8 Market Forecast (2026-2034)
  • 10.8 Shikoku Region
    • 10.8.1 Overview
    • 10.8.2 Historical and Current Market Trends (2020-2025)
    • 10.8.3 Market Breakup by Product
    • 10.8.4 Market Breakup by Technology
    • 10.8.5 Market Breakup by Application
    • 10.8.6 Market Breakup by End User
    • 10.8.7 Key Players
    • 10.8.8 Market Forecast (2026-2034)

11 Japan Molecular Diagnostics Market - Competitive Landscape

  • 11.1 Overview
  • 11.2 Market Structure
  • 11.3 Market Player Positioning
  • 11.4 Top Winning Strategies
  • 11.5 Competitive Dashboard
  • 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

  • 12.1 Company A
    • 12.1.1 Business Overview
    • 12.1.2 Services Offered
    • 12.1.3 Business Strategies
    • 12.1.4 SWOT Analysis
    • 12.1.5 Major News and Events
  • 12.2 Company B
    • 12.2.1 Business Overview
    • 12.2.2 Services Offered
    • 12.2.3 Business Strategies
    • 12.2.4 SWOT Analysis
    • 12.2.5 Major News and Events
  • 12.3 Company C
    • 12.3.1 Business Overview
    • 12.3.2 Services Offered
    • 12.3.3 Business Strategies
    • 12.3.4 SWOT Analysis
    • 12.3.5 Major News and Events
  • 12.4 Company D
    • 12.4.1 Business Overview
    • 12.4.2 Services Offered
    • 12.4.3 Business Strategies
    • 12.4.4 SWOT Analysis
    • 12.4.5 Major News and Events
  • 12.5 Company E
    • 12.5.1 Business Overview
    • 12.5.2 Services Offered
    • 12.5.3 Business Strategies
    • 12.5.4 SWOT Analysis
    • 12.5.5 Major News and Events

13 Japan Molecular Diagnostics Market - Industry Analysis

  • 13.1 Drivers, Restraints, and Opportunities
    • 13.1.1 Overview
    • 13.1.2 Drivers
    • 13.1.3 Restraints
    • 13.1.4 Opportunities
  • 13.2 Porters Five Forces Analysis
    • 13.2.1 Overview
    • 13.2.2 Bargaining Power of Buyers
    • 13.2.3 Bargaining Power of Suppliers
    • 13.2.4 Degree of Competition
    • 13.2.5 Threat of New Entrants
    • 13.2.6 Threat of Substitutes
  • 13.3 Value Chain Analysis

14 Appendix